Lung cancer surgery market set for $2.8b expansion by 2036 on rising cases

By region, India is emerging as the fastest-growing market, with a 7% CAGR.

The global lung cancer surgery market is projected to reach $2.8b by 2036, growing at a compound annual growth rate of 5.9%, driven by increasing lung cancer incidence.

According to a Future Market Insights report, market drivers also include the expansion of early diagnosis programs and technological advancements in surgical tools.

However, the high cost of advanced surgical systems, limited access to specialised surgical centres and late-stage diagnosis are standing in the market’s way.

By segment, segmentectomy (40%) leads due to its minimally invasive nature, whilst lobectomy and wedge resection remain widely used depending on tumour size and stage.

Hospitals (65%) dominate as primary end users due to advanced infrastructure and post-operative care capabilities.

By region, India (7% CAGR) is emerging as the fastest-growing market, whilst China (6.7% CAGR) benefits from large patient volumes and improving access to surgical care.